| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Annual report of the Japanese Breast Cancer Registry for 2019
|
Miyashita, Minoru
|
|
|
31 |
1 |
p. 16-23
|
artikel
|
| 2 |
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer
|
Iesato, Asumi
|
|
|
31 |
1 |
p. 63-74
|
artikel
|
| 3 |
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection?
|
Altundag, Kadri
|
|
|
31 |
1 |
p. 155
|
artikel
|
| 4 |
Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.
|
Horimoto, Yoshiya
|
|
|
31 |
1 |
p. 154
|
artikel
|
| 5 |
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study
|
Pelzer, Florian
|
|
|
31 |
1 |
p. 124-134
|
artikel
|
| 6 |
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study
|
Yoshida, Masahiro
|
|
|
31 |
1 |
p. 75-83
|
artikel
|
| 7 |
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels
|
Fathy, Amira
|
|
|
31 |
1 |
p. 116-123
|
artikel
|
| 8 |
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G
|
Jing, Rui
|
|
|
31 |
1 |
p. 135-147
|
artikel
|
| 9 |
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer
|
Fujiki, Yoshitaka
|
|
|
31 |
1 |
p. 31-41
|
artikel
|
| 10 |
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer
|
Pappot, Helle
|
|
|
31 |
1 |
p. 148-153
|
artikel
|
| 11 |
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan
|
Nishikawa, Yoshitaka
|
|
|
31 |
1 |
p. 105-115
|
artikel
|
| 12 |
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole
|
Takahashi, Masato
|
|
|
31 |
1 |
p. 53-62
|
artikel
|
| 13 |
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy
|
Williamson, Mellissa
|
|
|
31 |
1 |
p. 84-95
|
artikel
|
| 14 |
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study
|
Kong, Linghui
|
|
|
31 |
1 |
p. 42-52
|
artikel
|
| 15 |
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography
|
Uematsu, Takayoshi
|
|
|
31 |
1 |
p. 24-30
|
artikel
|
| 16 |
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer
|
Shen, Xiaowei
|
|
|
31 |
1 |
p. 96-104
|
artikel
|
| 17 |
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition
|
Honma, Naoko
|
|
|
31 |
1 |
p. 8-15
|
artikel
|
| 18 |
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition
|
Sakai, Takehiko
|
|
|
31 |
1 |
p. 1-7
|
artikel
|
Tijdschrift beschrijving